These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2114732)

  • 1. [Preventional and therapeutic effects of aldose reductase inhibitor FR74366 on rat galactose cataract].
    Tsuji T; Matsumoto Y; Mori K; Ikebe H; Terubayashi H; Akagi Y; Tanimoto T
    Nippon Ganka Gakkai Zasshi; 1990 Feb; 94(2):120-7. PubMed ID: 2114732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S; Kikuchi C; Ono T; Notsu Y
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat.
    Ao S; Shingu Y; Kikuchi C; Takano Y; Nomura K; Fujiwara T; Ohkubo Y; Notsu Y; Yamaguchi I
    Metabolism; 1991 Jan; 40(1):77-87. PubMed ID: 1898618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 5. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prefeeding of aldose reductase inhibitor inhibits galactose cataract].
    Tsuji T; Okamoto S; Ikebe H; Terubayashi H; Akagi Y; Tanimoto T
    Nippon Ganka Gakkai Zasshi; 1993 Apr; 97(4):455-9. PubMed ID: 8317365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and reversal of rat galactosemic cataract with aldose reductase inhibitor--immunohistochemical study].
    Akagi Y; Kador PF; Kinoshita JH; Tasaka H; Nakaji Y; Itoi M
    Nippon Ganka Gakkai Zasshi; 1985 Nov; 89(11):1276-81. PubMed ID: 3937449
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
    Akagi Y; Ikebe H; Terubayashi H; Takahashi Y; Tsuji T
    Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):494-500. PubMed ID: 2508449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Varagiannis E
    Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative study of rat diabetic cataract, by the relaxation times of nuclear magnetic resonance].
    Mori K; Terubayashi H; Akagi Y; Okamoto S; Tsutsumi M; Ikebe H; Yoshizaki K; Nishikawa H
    Nippon Ganka Gakkai Zasshi; 1991 Apr; 95(4):336-42. PubMed ID: 1908617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G; Leuenberger PM
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Movement of regenerated lens epithelial cells in 50% galactose cataract and an aldose reductase inhibitor].
    Terubayashi H; Tsuji T; Matumoto Y; Ikebe H; Akagi Y
    Nippon Ganka Gakkai Zasshi; 1989 Nov; 93(11):1044-53. PubMed ID: 2513712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 15. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
    Unakar NJ; Tsui JY; Johnson MJ
    Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
    Ohrloff C; Hockwin O; Korte I; Wegener A
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications.
    Varma SD
    Prog Clin Biol Res; 1986; 213():343-58. PubMed ID: 3086893
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract.
    Beyer-Mears A; Kelly K; Cruz E
    Pharmacology; 1985; 31(3):170-9. PubMed ID: 3931105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.